©The Author(s) 2026.
World J Diabetes. Jan 15, 2026; 17(1): 113821
Published online Jan 15, 2026. doi: 10.4239/wjd.v17.i1.113821
Published online Jan 15, 2026. doi: 10.4239/wjd.v17.i1.113821
Table 1 Results of the follow-up in the past 5 years
| Time | Fasting C-peptide (ng/mL) | Postprandial C-peptide (ng/mL) | Fasting insulin (IU/mL) | Postprandial insulin (IU/mL) | HbA1c | Urine sugar | Urine ketone bodies |
| 2011 | 8.09 | 25.32 | 272.4 | > 1000 | 5.6% | + | + |
| 2019 | 7.67 | 22.37 | 328.36 | 327.99 | 8.6% | 3+ | 4+ |
| 2022 | 7.17 | 20.2 | > 200 | > 200 | 13% | 4+ | 4+ |
| 2023 | 4.9 | 17.8 | > 200 | > 200 | 12.6% | 3+ | 4+ |
| 2024 | 4.5 | 16.7 | > 200 | > 200 | 11.2% | 3+ | 4+ |
| 2025 | 3.07 | 14.3 | > 200 | > 200 | 11.5% | 2+ | 3+ |
- Citation: Wang K, Zheng J, Gu LC, Li RR, Su XD, Bai J, Liao L. Rabson-Mendenhall syndrome caused by a novel splice-site mutation (c.1123+2 T>C) of insulin receptor: A case report and review of literature. World J Diabetes 2026; 17(1): 113821
- URL: https://www.wjgnet.com/1948-9358/full/v17/i1/113821.htm
- DOI: https://dx.doi.org/10.4239/wjd.v17.i1.113821